Difficulty: Medium
Average Score: 78%
Testbank
The nurse is instructing a client about the use of pegvisomant for the treatment of acromegaly. How will the nurse instruct to take this medication?
Correct answer
A
Rationale
Injected subcutaneously once a day is the appropriate method for taking pegvisomant for the treatment of acromegaly. This medication is designed to be administered daily via subcutaneous injection to effectively manage growth hormone receptor antagonism, thereby reducing the symptoms associated with acromegaly.
B: Injected intramuscularly once a month fails to align with pegvisomant's administration guidelines, as it is not intended for intramuscular use and requires more frequent dosing than once a month.
C: Administer via an implanted port once a month is not applicable since pegvisomant is not delivered through an implanted port, and its dosing schedule does not support monthly administration.
D: Injected intramuscularly once every 6 months does not meet the necessary frequency for pegvisomant administration, which is required to be daily to maintain therapeutic effectiveness.
B: Injected intramuscularly once a month fails to align with pegvisomant's administration guidelines, as it is not intended for intramuscular use and requires more frequent dosing than once a month.
C: Administer via an implanted port once a month is not applicable since pegvisomant is not delivered through an implanted port, and its dosing schedule does not support monthly administration.
D: Injected intramuscularly once every 6 months does not meet the necessary frequency for pegvisomant administration, which is required to be daily to maintain therapeutic effectiveness.